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Abstract 
 
Objective: Illness management and recovery (IMR) is a standardized 
psychosocial intervention designed to help people with severe mental illness 
manage their illness and achieve personal recovery goals. This article 
summarizes the research on consumer-level effects of IMR and the literature on 
implementing IMR.  
 
Methods: A literature search in EMBASE, MEDLINE, PsycINFO, CINAHL, and 
the Cochrane Library was conducted using keywords “illness management and 
recovery,” “wellness management and recovery” or [“IMR” AND (“schizophrenia” 
OR “bipolar” OR “depression” OR “recovery” OR “mental health”)]. Publications 
citing two seminal IMR articles also guided further exploration of sources. Articles 
were excluded if they did not deal explicitly with IMR or a direct adaptation. 
 
Results: Three randomized-controlled trials (RCTs), three quasi-controlled, and 
three pre-post trials have been conducted. Outcomes from the RCTs were strong 
for improved self-reported and clinician-reported IMR Scale scores and 
independent assessor rated symptoms. Implementation studies identified several 
important barriers and facilitators of IMR, including IMR supervision and agency 
support. Implementation outcomes (e.g., participation rates and fidelity) varied 
widely.  
 
Conclusions: IMR shows promise for improving some consumer-level 
outcomes. Important issues regarding implementation require additional study. 
Future research is needed comparing IMR to active controls and/or that provide 
more detailed descriptions of other services utilized by participants.   
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The Illness management and recovery (IMR) program is a standardized 
psychosocial intervention designed to help people with severe mental illness 
better manage their illness and achieve personally meaningful goals (1, 2). IMR 
was created in conjunction with the National Implementing Evidence-Based 
Practices Project (3), with the aim of incorporating empirically supported illness 
self-management strategies into a single program.  
IMR is organized into topical modules, each of which requires several 
sessions to teach, using a combination of motivation-based, educational, and 
cognitive-behavioral strategies. The modules are premised on the stress-
vulnerability model (2, 4) and therefore include information on mitigating 
biological vulnerabilities and psychosocial stressors, as well as developing 
“recovery strategies” such as relapse prevention plans. The Third edition of IMR 
includes the following 11 modules: recovery, practical facts about mental illness, 
the stress-vulnerability model, building social support, drugs and alcohol, 
reducing relapses, coping with stress, coping with persistent symptoms, getting 
your needs met in the mental health system, and living a healthy lifestyle. IMR 
can be delivered in a group or individual format. 
 Resource materials have been developed to facilitate the implementation 
of IMR, including a practitioner’s guide, the IMR Workbook (including educational 
handouts for each topic), the IMR fidelity scale, outcome measures, informational 
brochures for different stakeholders (e.g., consumers, family members, clinicians, 
policy makers), and introductory and demonstration videos. 
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 Although the IMR program has strong empirical foundations by 
incorporating evidence-based strategies for improving illness self-management, 
unlike other practices in the National Implementing Evidence-Based Practices 
Project, IMR as a package had not been previously evaluated. Since the IMR 
program and resource materials became publically available for free on a 
SAMHSA website, IMR has been increasingly implemented throughout the U.S. 
and internationally, and has been the focus of growing research. This paper 
provides a systematic review of research on the IMR program including the 
effects of IMR on consumer outcomes and service utilization, implementation of 
IMR, and modifications to the program. 
 
Methods 
 
In June 2011 we searched EMBASE, MEDLINE, PsycINFO, CINAHL, 
and the Cochrane Library (i.e. CCTR, DARE, HTA), using the keywords “illness 
management and recovery,” “wellness management and recovery” or “IMR” AND 
[(“schizophrenia” OR “bipolar” OR “depression” OR “recovery” OR “mental 
health”)] generating 37 references after duplicates were removed. We also 
searched for publications citing two seminal IMR articles (1, 2) resulting in 223 
publications after removing duplicates. The inclusion criteria for our review 
included publications that dealt explicitly with IMR or described the program of 
study as an adaptation of IMR.  Publications that simply described of the creation 
of the IMR program were excluded. We also excluded reports not published in 
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peer-reviewed journals to ensure the highest scientific rigor. Twenty-six studies 
met inclusion criteria, including ten studies measuring consumer outcomes and 
sixteen studies examining implementation and/or adaptations of IMR. One study 
(Roe and colleagues; 5) was a qualitative follow-up of a prior study (6) and did 
not report unique quantitative consumer outcomes; however, because it provided 
implementation outcomes (completion rates) we included it in the review of 
implementation studies. 
 
Results 
 
Consumer Outcomes and Service Utilization 
 Randomized-Controlled Trials (RCTs). Three RCTs compared IMR to 
treatment as usual (6-8) (Table 1). Hasson-Ohayon and colleagues (6) examined 
IMR in thirteen community agencies in Israel offering IMR for 8 months. Levitt 
and colleagues (7) examined IMR implemented within residential programming in 
New York City; follow-up was conducted post-treatment and six months later. 
Finally, Färdig and colleagues (8) examined IMR in six Swedish psychosocial 
rehabilitation centers at post-treatment and 21-month follow-up. Treatment as 
usual varied considerably both within and between studies, but generally 
included outpatient case management, pharmacological treatment, and access to 
other rehabilitation services. 
The Illness Management and Recovery scales (IMRSs) were created in 
conjunction with the IMR Implementation Toolkit (9) in order to provide a practical 
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measure of the progress of a consumer participating in IMR. Questions reflect 
specific IMR program targets, such as progress towards goals, knowledge of 
mental illness, having a relapse prevention plan, and substance use. Consumer-
reported IMRS scores improved more in IMR in both Färdig (8) and Levitt (7) 
(both medium effect sizes); overall, IMRS scores in Hasson-Ohayon (6) did not 
favor IMR until analyses were narrowed to sites with high IMR fidelity—at which 
point the IMR group showed better improvement (Table 2).  
 Consumers in IMR reported significant differences on four subscales of 
the Ways of Coping Scale in one RCT (8), but did not show any differences in 
coping in another (6). However, consumers in IMR did not report greater 
improvement than controls on symptoms (Modified Colorado Symptom Index (7, 
10)), recovery (Recovery Assessment Scale (8, 11)), quality of life (Manchester 
short assessment of quality of life (8, 12)), or social support (Multidimensional 
Scale of Perceived Social Support (6, 13)). Notably, there were no time effects 
for either IMR or control clients on these outcomes.  
Independent assessor evaluated outcomes were generally more 
encouraging. Consumers in IMR were rated as having greater symptom 
reduction than controls in both RCTs that examined this variable (7, 8); small and 
medium effect sizes, respectively), as well as better psychosocial functioning on 
an abbreviated version of Heinrich’s Quality of Life Scale (7).  
There were no significant differences between groups in hospitalization, 
as measured by self-report (7), record review (8), and an unreported method (6). 
No study found improvements in employment (7) rate or changes in medication 
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dosage (8). Finally, clinicians in all three RCTs (6-8) rated consumers in IMR as 
improving more on the IMRS than those receiving usual care (effect sizes small 
and medium). Notably, though, clinicians were not blind to condition.  
Quasi-Controlled and Pre-Post Trials. Three studies compared IMR to a 
non-randomized control group. Fujita and colleagues (14) compared an IMR 
group within a day treatment program in Japan to a convenience control group at 
another location. In two separate analyses (using partially overlapping samples) 
Salyers and colleagues (15, 16) compared consumers on assertive community 
treatment (ACT) teams in Indiana receiving IMR to consumers on ACT not 
receiving IMR. In both studies, ACT team members determined who would 
receive IMR based on their own clinical judgment. Three studies examined 
change over time in consumers receiving IMR (2, 17, 18).  
Results from quasi-controlled and pre-post studies are reported when 
they differ from RCTs. These trials showed improvement over time for IMR on 
consumer-reported recovery (2, 17, 18), generally measured by the RAS, 
whereas Färdig’s RCT found no improvement for IMR consumers on this same 
scale. Consumer-reported psychiatric symptoms decreased in two quasi-
controlled studies (2, 14); whereas Levitt (7) found no improvement. In short, the 
effects of IMR on consumer reported recovery and symptoms remains promising, 
but require further exploration.   
Although satisfaction with services was not measured in any of the RCTs, 
three quasi-controlled studies (2, 15, 17) measured satisfaction, with only one (2) 
reporting significantly greater increases in satisfaction over time.  
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Salyers and colleagues (15, 16) examination of ACT consumers is 
notable in two regards. First, they found no advantage for IMR on consumer or 
clinician-rated outcomes, with both IMR and control groups improving over time 
on the clinician IMRS, and neither improving over time on the consumer IMRS. 
Second, they reported an advantage for consumers who received IMR on 
hospitalization rates compared to those who received usual ACT services. 
 In summary, extant research suggests an advantage for IMR over 
treatment as usual for the consumer and clinician-rated IMRS and interviewer-
rated symptoms. Evidence from quasi-controlled trials indicates that consumers 
participating in IMR improve in their self-rated recovery, but this was not 
confirmed in the one RCT evaluating this hypothesis. Evidence is lacking for 
IMR’s effects on more distal outcomes such as quality of life, social support, and 
community integration and role functioning. Additional research is necessary to 
determine the differential effects of treatment setting and consumer population. 
 
Implementation and Adaptation of IMR 
Sixteen studies reported on the implementation and/or the modification of 
IMR. These studies included results from the National Implementing Evidence-
Based Practices Project (19-23); other publications included thorough 
descriptions of IMR implementation efforts at a psychiatric rehabilitation center 
(24), a state psychiatric hospital (25), and community mental health centers in 
the US and Israel (26). Other publications focused on the adaptation of the IMR 
model, either for a novel setting or purpose (27-29) or to overcome perceived 
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barriers to implementation (30, 31). Finally, several studies examined staff 
perceptions of IMR training (32-34). We will first describe the results of the 
National Implementing Evidence-Based Practices Project and then summarize 
research on the implementation and adaptation of IMR, guided by the 
Consolidated Framework for Advancing Implementation Research (35).  
The National Implementing Evidence-Based Practices Project was the 
first large-scale study to examine the implementation of IMR (19, 21). This 
project included the implementation of IMR and other evidence-based practices 
using comprehensive implementation support (i.e., a site implementation 
coordinator, training, and fidelity monitoring) (22). Evaluation focused on fidelity 
and qualitative data on the implementation process. Fifty percent of sites 
participating in the National Implementing Evidence-Based Practices project 
reached average fidelity of four or greater, which is considered “successful 
implementation” (21) during the two-year study period; in general, scores 
progressed over time, with the largest gain realized in the first six months, with 
continued improvement for the remainder of the first year and sustained scores 
for the next year. Some authors (19, 21) emphasized the difference between the 
IMR Fidelity Scale, which relies heavily on clinical techniques (e.g., motivational, 
cognitive-behavioral, and educational teaching techniques), and other fidelity 
scales that are defined more in structural terms (e.g., team composition, location 
where services are provided), such as assertive community treatment and 
supported employment. Investigators suggested this difference in emphasis 
leads to lower fidelity ratings for IMR, similar to other the fidelity scales of other 
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practices that rely on clinical techniques, such as integrated dual-disorder 
treatment and family psychoeducation (19, 21). However, these results must be 
considered in context—the IMR fidelity scale has had little psychometric 
validation and the cut-off for “successful implementation” is based on expert 
opinion rather than empirical validation. 
Adaptations of IMR. Several groups have developed programs based on 
IMR. Bullock and colleagues (31) adapted IMR and combined it with another 
program—the Ohio Medication Algorithm Project -- in order to create wellness 
management and recovery (WMR). WMR covers similar topics as IMR and 
focuses on consumer empowerment and goal setting. Reported differences from 
IMR include: 1) a 10-week curriculum (delivered in two-hour groups, once per 
week), 2) a requirement for a peer co-facilitator, 3) an emphasis on cultural 
competence. In a longitudinal, mixed-methods program evaluation, WMR 
graduates showed significant improvement on self-reported recovery and 
reduction in symptoms between baseline and following treatment (31). These 
changes were maintained at a follow-up assessment conducted between 3-6 
months following discharge.  
Wellness Self-Management (WSM). Salerno and colleagues’ (30) 
adaption of IMR departs from traditional IMR in three key ways. Most 
significantly, consumers in WSM do not set long-term recovery goals. In addition, 
a greater emphasis was placed on “wellness action steps” rather than homework 
assignments within the program curriculum.  WSM is currently offered in over 
100 mental health agencies in New York. The published evaluation reports 
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  
improvement in goal progress; however, not enough information was provided to 
include this as an outcome study in our review above(30).  
 
Factors Affecting Implementation 
The Consolidated Framework for Implementation Research (35) outlines 
five domains that influence implementation of a practice: intervention 
characteristics, outer setting, inner setting, characteristics of individuals providing 
the practice, and the implementation process.  
 Intervention characteristics. IMR is a complex intervention, involving the 
integrated use of high-level clinical skills such as motivation-based and cognitive-
behavioral strategies used to teach the IMR curriculum.  The manual was 
generally considered a strength of IMR—surveyed trainees often appreciated the 
structured, manualized approach (32). While providing structure, the IMR 
curriculum allows a fair degree of flexibility in pace and usage of techniques, with 
guidelines (rather than prescriptions) of suggested activities within sessions and 
for homework. Some IMR modifications have increased the prescriptive nature of 
the curriculum (30, 31), with substantially briefer time frames for program 
completion. Others have added topics to the curriculum, including an increased 
emphasis on medications (31), physical health (29, 30), and anger management 
(27). 
Inner Setting. In general, factors involving the inner setting of the agency 
and/or program implementing IMR were highlighted as the most important 
facilitators of implementation in a number of studies. In empirical examinations of 
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IMR trainees (32), and as reported by the National Implementing Evidence-
Based Practices Project (20), agency-level factors were mentioned most often. In 
particular, agency culture (36) such as policies and procedures were highlighted. 
Supervision specific to IMR, which provides a format for continued learning and 
reinforcement of the clinical techniques, was emphasized by several authors (19, 
20, 24, 25, 32). Several sources also highlighted the importance of adapting 
clinical documentation to support IMR (24, 25, 32). Bartholomew (25) 
emphasized the importance of communicating the work being done in IMR-such 
as setting clearly defined recovery goals and delineating skills to be learned-to 
other members of the treatment team.  
Agency philosophy, particularly an agency’s embrace of recovery, may 
affect IMR implementation. Because IMR may require a fundamental shift in an 
agency toward recovery-oriented practice, Isett recommended agency-wide 
training in IMR (23) and also noted the importance of fit of IMR with other 
programs within a setting. Importantly, in studies of recovery-related staff 
training, including IMR training, training was positively associated with staff 
optimism regarding consumers and perceived recovery orientation (33, 34).  
 Outer Setting. Factors external to the agency implementing IMR have 
also been identified as important. State-wide consensus building was considered 
key in the National Implementing Evidence-Based Practices Project (22). 
Similarly, state technical assistance has been associated with increased reports 
of full implementation (32).  Funding is also crucial.  Rychener and colleagues 
(24) described that high expectations for productivity in terms of billable services 
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make participation in non-billable activities that support IMR (e.g., supervision, 
steering committees, training) difficult. However, they reported this cost was 
partly offset by increased productivity due to IMR; clinicians who were previously 
providing brief case-management were able to deliver IMR services for longer 
periods of time. 
  Implementation Process. All published accounts of IMR implementation 
used a multifaceted implementation strategy involving training, IMR-specific 
supervision, technical assistance, and fidelity monitoring. Implementation support 
was generally very robust and spanned across domains of implementation. 
Implementation across studies generally included some form of external 
facilitation, including academic detailing (24, 25, 37) or technical assistance (15, 
17, 19, 30, 31). Efforts in New York differ in the use of a learning collaborative 
(30) that served many of the same functions of a state technical assistance 
center, but was funded in part by financial commitments from participating 
agencies.  
 Individuals providing IMR. IMR has been generally provided by 
professional clinicians, though some treatment settings utilize consumer 
providers (15, 18, 31). Many implementation efforts began with a pilot group, 
generally with the most willing and enthusiastic clinicians, and expanded to 
additional programs and clinicians (24, 25, 30, 38). Because IMR is a manualized 
program, clinicians must be willing to adapt to a more structured intervention 
(24). Additionally, clinicians with paternalistic or medical-model philosophies may 
not be well-suited for IMR. For example, in the Rychener (24) implementation, 
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the agency placed new emphasis on clinical supervision and fidelity monitoring 
that was difficult for clinicians unaccustomed to such a level of oversight.  
However, despite a given clinician’s preconceptions, IMR may provide a platform 
for paternalistic practitioners to challenge their beliefs and increase their recovery 
orientation (33, 34).  
 
Implementation Outcomes  
IMR studies reported three types of implementation outcomes: feasibility, 
fidelity, and penetration (see Table 3). Feasibility-- the extent to which a practice 
can be used or carried out within a setting (39)-- is often measured by 
recruitment, retention, and participation rates (40). One factor relevant to 
feasibility is the program length. Although initially conceptualized as a three to six 
month program, more recent literature (17) has suggested IMR takes longer (9-
12 months).  
The median dropout rate across nine studies reporting (2, 6, 8, 14-17, 25, 
41) was 24% and dropout rates were rather consistently within the 20%-30% 
range (2, 6, 15, 17, 18, 41). In terms of lower dropout rates, Fujita and 
colleagues’ (14) and Färdig and colleagues (8) found particularly low dropout 
rates (14% and 5%, respectively). Participants in Färdig’s sample were selected 
based on consistent attendance, and training and consultation focused heavily 
on consumer engagement (Färdig, personal communication, 12/19/12). Despite 
cross-study consistency in dropout rates, substantial variability exists between 
sites within some studies (e.g., 10%-50% (17), 24%-40% (2)).  
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Program completion was generally defined as having received all 10 
modules; seven studies (2, 14-16, 18, 26, 41) reported completion rates, with a 
median rate of 63%. Unlike dropout rate, completion rates varied substantially 
between studies (range = 15%-86%). Salyers and colleagues (15) found a 
particularly low completion rate in their two year examination of ACT teams 
(15%); this rate only increased to 47% when retrospectively examining the full set 
of ACT-IMR programs within the state over a five year span (16). A trend does 
appear between sites providing group versus individual format; all studies 
providing IMR in a group format were at or above the median completion rate. 
Three studies (7, 8, 14) reported the percentage of sessions attended. 
Average percent of sessions were 75% (8) and 82% (14). Levitt (7) reported 54% 
of participants attended at least 21 out of 41 sessions of sessions.   
Fidelity, or the level of adherence to the program model, was examined in 
seven studies. In the National Implementing Evidence-Based Practices Project 
(19) 50% of sites reached average scores meeting the criterion for “successful 
implementation” (i.e., greater than 4.0) (21) with an addition 25% obtaining 
“moderate implementation” (i.e., greater than 3.0). Hasson-Ohayon and 
colleagues’ (6) multi-site RCT found cross-site variability in fidelity, ranging from 
2.7 to 4.8, with eight out of eleven programs reaching “moderate” fidelity (42). 
Importantly, Hasson-Ohayon found consumer IMR scale outcomes were stronger 
at high-fidelity sites than at low fidelity sites. All sites in four out of five 
subsequent studies (7, 14, 15, 17) reached fidelity greater than 4.  
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Penetration, or “the integration of a practice within a service setting,”(40) 
can be measured in terms of the number of eligible consumers receiving a 
service or number of clinicians adopting the practice. Only two related studies 
examined penetration at the consumer level (15, 16) and found that only 26% 
and 29% of consumers on ACT teams received IMR.  
 In summary, IMR appears to be feasible to implement, with consumer 
acceptability within the range found in other evidence-based practices. 
Completion rates were better for group IMR than for individual IMR. Nonetheless, 
both median dropout (about 24%) and completion rates (63%) leave much room 
for improvement. Acceptable rates of fidelity were found in later trials, but earlier, 
more geographically spread-out trials found substantial variability. Penetration 
was infrequently reported, but was poor in the few trials that did.  
 
Discussion 
 This review yielded a substantial amount of research on IMR. Ten studies 
of client outcomes and 16 implementation studies have been published since the 
creation of the program. Research has spanned numerous treatment settings 
across several continents. Outcomes research examined changes in consumer 
outcomes before and after participating in IMR, with three RCTs comparing IMR 
to treatment as usual. The most consistently positive findings were improvements 
in the IMR Scales, which were specifically designed to assess IMR outcomes 
and objectively-rated symptoms. Other evaluations of consumer-reported 
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recovery were generally (but not uniformly) positive. Other subjective and 
objective outcomes varied considerably between studies.  
 Although the current research is promising, modifications to future studies 
could greatly enrich the information gleaned about IMR and its potential 
applications. First, the three RCTs did not compare IMR to an active control 
group; therefore, results cannot disentangle specific effects of IMR from common 
factors. Moreover, “treatment as usual” was often poorly delineated; therefore, it 
is unclear within what treatment regimens IMR can be added with positive 
effects. Other services utilized by participants should be tracked and taken into 
account. Regarding reporting, few studies reported effect sizes; therefore it is 
difficult to assess its impact on results. 
Second, IMR is a complex and multi-faceted intervention, with potential 
effects on multiple consumer domains, through various mechanisms of action. 
The studies generally included multiple outcomes, but without a clear linkage 
between the relevant element of IMR and its putative outcomes. Future research 
should include analyses informed by the theoretical foundations of IMR (i.e., the 
modified stress-vulnerability model(2, 43)).  
Regarding the reduction in hospitalization, two explanations seem 
plausible. Either IMR and ACT work synergistically to reduce risk of 
hospitalization or ACT-IMR clinicians chose to provide IMR to consumers (either 
intentionally or unintentionally) with the least risk for re-hospitalization The low 
rates of hospitalization in the 3 RCTs suggests that well stabilized outpatients 
were included, reducing the likelihood of finding reductions in hospital use.  Also, 
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no study has looked at the effects of IMR on reducing relapses/hospitalizations in 
people with a recent hospitalization, who are more vulnerable to 
rehospitalizations.  In addition, studies generally did not report on the effects of 
potential consumer-level (e.g., illness severity, intellectual capability, other 
services received) and agency-level (e.g., climate and culture, client-to-staff ratio) 
moderating variables that could affect consumer outcomes.  
 Although implementation outcomes suggest that IMR can be successfully 
implemented and has been accepted by consumers reasonably well, 
implementation success and acceptance merit further exploration. Dropout rates 
were generally consistent (between 20-30%) and within the range found in 
studies of CBT for psychosis (where the dropout rate generally ranges between 
35%-55% (44)) and general outpatient services (45). Extant studies did not 
examine predictors of dropout; studies examining predictors of dropout of 
consumer with severe mental illness more generally have found little consensus 
regarding predictors of dropout (however, see (46)). Completion rates varied 
more than dropout rates, with the lowest rates found in two studies of IMR on 
ACT teams. Due to the severity of illness experienced by consumers on ACT 
teams, it is reasonable that these consumers may require a longer period to 
complete the IMR curriculum. These studies also found a lower hospitalization 
rate for ACT consumers receiving IMR, so it would be premature to determine 
that IMR is not useful for ACT consumers. It is also unclear what effects socio-
economic factors may have on acceptability (e.g., literacy, multiple role 
pressures) of IMR. 
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 Fidelity was considered acceptable in all outcome studies in which it was 
measured, except in Hasson-Ohayon and colleagues (6), where it varied across 
sites (consistent with fidelity results in the National Implementing Evidence-
Based Practices project). Low fidelity was found in studies that spanned across 
state lines and one trial that was conducted in an inpatient setting. Geographical 
dispersion may be a limitation for consistently rigorous training and technical 
assistance.  
Although fidelity is considered an important implementation outcome, the 
IMR fidelity scale has several limitations. First, the cut-point for “success” 
implementation has not been scientifically validated. Second, the scale focuses 
on program-level fidelity, which does not take into account variation between 
clinicians on IMR competence. To this end, a group is currently validating a IMR 
competence tool—the IMR Treatment Integrity Scale (IT-IS; 47). In addition to 
fidelity outcomes, costs are also critical.  No study reported costs of 
implementation—an important practical consideration for implementation. 
 Implementation studies identified several important barriers and 
facilitators of IMR; however, methodologies preclude drawing conclusions 
regarding the effect of particular factors on specific implementation outcomes. 
The most consistent results were the importance of agency factors, in particular 
regular supervision, and contact with outside training and consultation. Future 
studies should examine the interplay between various implementation domains.
 Clinical implications. IMR appears to be a successful and well-tolerated 
intervention for people with severe mental illness. As of yet, no population has 
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emerged that does not generally benefit from the program, although clinical 
correlates of success have been largely ignored. More work is necessary to 
adapt IMR to special populations (e.g., criminal justice involved). 
  
Conclusions 
 
 IMR was initially called an evidence-based practice based on research on 
its components; research on IMR as a package is promising, displaying positive 
effects on consumers’ perceptions of recovery including improved coping and 
illness management. Methodological issues do not allow for firm conclusions 
regarding IMR’s effectiveness in comparison to other services. IMR programs 
can achieve acceptable fidelity, but this may require substantial and 
comprehensive implementation support. Agency support (including supervision) 
and external consultation appear to be key facilitators of implementation. Future 
research should include active control groups, more psychometrically rigorous 
outcome measures, and examine key moderators of participation and outcomes. 
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Table	  1:	  Description	  of	  Illness	  Management	  and	  Recovery	  Outcomes	  Studies	  
Citation	   Design	   Follow-­‐up	   N6	   Program	  Setting	   Format2	   IMR	  Length	   Clinicians	   Training	  
Hasson	  et	  al.,	  2007	   RCT1	   Graduation	   210	   13	  Israeli	  Psychiatric	  
rehabilitation	  centers	  	  
	   8-­‐11	  months	   13	  “Interested”	  
clinicians	  
	  
48	  Hours	  
Levitt	  et	  al.,	  2009	   RCT1	   5	  Months;	  
12	  Months	  
104	   3	  Multiunit	  
Supportive	  Housing	  
Programs	  
2/Week	   41	  sessions	   ?	   ?	  
Färdig	  et	  al.,	  2011	   RCT1	   9	  Months;	  
21	  Months	  
41	   6	  Psychiatric	  
Outpatient	  Rehab.	  
Centers;	  Sweden;	  	  
	   9	  Months	  
(Mean	  =	  30	  
Sessions)	  
12	  “Interested”	  
clinicians	  
	  
5	  Days	  
Fujita	  et	  al.,	  2010	   Non-­‐Randomized	  
Control4	  
Graduation	   N	  =	  25	  
	  
Outpatient	  clinic	  at	  2	  
hospitals	  in	  Japan	  
Weekly/Bi
weekly4	  
Mean	  =	  28	  
Sessions	  
Various	  
Professions	  
2	  Days	  	  
Salyers,	  McGuire,	  
et	  al.,	  2010	  
Non-­‐Randomized	  
Control3	  
24	  Months	   N	  =	  324	   4	  ACT	  teams	   Individual	   ?	   Peer	  specialist	  +	  
ACT	  case	  
managers	  	  
2	  Days	  
Salyers,	  Rollins,	  et	  
al.,	  2011	  
Non-­‐Randomized	  
Control	  
5	  Years	   n	  =	  498	  (144	  
IMR)	  
5	  ACT	  Teams	   Individual	   Median	  =	  9	  
Months	  
Peer	  specialist	  +	  
ACT	  CM	  	  
2	  Days	  
Mueser	  et	  al.,	  2006	   Pre-­‐Post	   3	  Months	  
Post-­‐IMR	  
N	  =	  31	   CMHCs	  in	  US	  and	  
Australia	  
Group/Indi
vidual	  
8	  Months5	   Various	  
Professions	  
2	  Days	  
Salyers,	  Godfrey,	  et	  
al.,	  2009	  
Pre-­‐Post	   12	  Months	   n	  =	  324	  (BL);	  	   6	  CMHC	  in	  IN;	  
various	  programs	  
Group/Indi
vidual	  
?	   Varied	  by	  Site	   2	  Days	  +	  
Suppleme
ntal	  
Salyers,	  Hicks,	  et	  
al.,	  2009	  
Pre-­‐Post	  	   9	  Months	   N	  =	  14	   ACT	  Team,	  CMHC	   Individual	   ?	   Peer	  specialist	   40	  hours	  
Notes:	  All	  studies	  focused	  on	  consumers	  with	  severe	  mental	  illness.	  	  
1Randomized	  controlled	  trial	  comparing	  IMR	  to	  “treatment	  as	  usual.”	  	  
2IMR	  was	  provided	  in	  weekly	  groups,	  unless	  otherwise	  noted.	  
3Two	  ACT	  teams	  randomly	  assigned	  to	  receive	  IMR	  training	  and	  peer	  support,	  two	  maintained	  treatment	  as	  usual.	  
4Fujita	  et	  al.	  included	  a	  small	  wait-­‐list	  control.	  Two	  consumers	  opted	  for	  individual	  IMR	  rather	  than	  group.	  
5Based	  on	  weighted	  mean	  of	  time	  to	  program	  completion	  across	  sites.	  
6Ns	  are	  total	  number	  of	  participants	  enrolled	  in	  the	  study.
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Table	  2:	  Results	  of	  Illness	  Management	  and	  Recovery	  Studies	  
	   Randomized	  Control	   Non-­‐Randomized	  
Controlb	  
	   Pre-­‐Post	   	  
Variable	   Hasson-­‐
Ohayon	  et	  
al.,	  2007	  
Levitt	  et	  
al.,	  2009	  
Fardig	  et	  
al.,	  2011	  
Fujita	  et	  
al.,	  2010	  
Salyers	  et	  
al.,	  2010,	  
2011	  
Mueser	  et	  
al.,	  2006	  
Salyers,	  
Godfrey,	  
et	  al.,	  
2009	  
Salyers,	  
Hicks,	  et	  
al.,	  2009	  
Consumer	  Reported	   	   	   	   	   	   	   	   	  
IMR	  Scaleb	   NS	   Y	   Y	   	   NS	   Y	   Y	   	  
Recovery-­‐related	  scales	   	   	   NS	   NS	   NS	   Y	   Y	   Y	  
Coping	   NS	   	   Yc	   	   	   NS	   	   	  
Knowledge	  About	  Mental	  Illness	   Yd	   	   	   	   	   Y	   	   NS	  
Psychiatric	  Symptoms	   	   NS	   	   	   	   Y	   	   	  
Satisfaction	  with	  Services	   	   	   	   	   NS	   	   NS	   	  
Quality	  of	  Life/	  Community	  
Functioning	   NS	   	   NS	   Y	  
	   	   	   	  
Clinician	  Reported	   	   	   	   	   	   	   	   	  
IMR	  Scale	   Y	   Y	   Y	   	   NS	   	   Y	   	  
Quality	  of	  Life/	  Community	  
Functioning	   	   Y	   	   NS	  
	   	   	   	  
Symptoms	   	   	   	   NS	   	   	   	   	  
Substance	  Abuse	   	   NS	   	   	   Y	   	   	   	  
Observer-­‐Rated	   	   	   	   	   	   	   	   	  
Psychiatric	  Symptoms	   	   Y	   Y	   	   	   	   	   	  
Objective	  Outcomes	   	   	   	   	   	   	   	   	  
	  	  	  Hospitalizations/ER	   NS	   NS	   NS	   	   NS/Y	   	   	   	  
	  	  	  Employment	   	   NS	   	   	   NS	   	   	   	  
	  	  	  Medication	  Dosage	   	   	   NS	   	   	   	   	   	  
	  	  	  Incarceration/	  Homelessness	   	   	   	   	   NS	   	   	   	  
Note:	  Significance	  reported	  for	  total	  scale	  scores,	  analyzed	  from	  baseline	  to	  the	  longest	  follow-­‐up	  period.	  Only	  one	  scale	  measured	  in	  each	  category.	  Y	  =	  
significant	  (<.05)	  finding	  in	  that	  category;	  NS	  =	  no	  significant	  finding;	  Blank	  =	  not	  measured.	  
aIMR	  vs.	  control	  
bIMR	  scale	  scores	  were	  total	  scale	  scores;	  other	  reported	  variables	  were	  never	  derived	  from	  IMR	  scale	  items.	  	  
cThe	  Ways	  of	  Coping	  Scale	  does	  not	  produce	  a	  total	  score:	  4/8	  subscales	  were	  significant.	  
dAlthough	  no	  specific	  knowledge	  measure	  was	  administered,	  there	  was	  a	  significant	  change	  in	  the	  “Knowledge	  and	  Goals”	  subscale	  of	  the	  IMR	  Scale-­‐	  Client	  
Version.	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Table	  3:	  Implementation	  Studies	  of	  Illness	  Management	  and	  Recovery	  
Citation	   Dropout	  
Rate	  
%	  Sessions	  Attended	   Graduation/	  
Completion	  	  
Rate	  
Fidelity	  
(M±SD)5	  
Hasson-­‐Ohayon	  et	  al.,	  
2007(6)	  
18%1	   NR	  	   	  NR	   	  2.66	  to	  4.77	  
Levitt	  et	  al.,	  2009	  (7)	   	  NR	  (“low	  	  
exposure	  	  
rate”)	  
54%	  attended	  50%	  
sessions	  
	  NR	   	  	  4.38±1.19	  
Färdig	  et	  al.,	  2011(8)	   	  5%	   	  75%	   	  NR	   	  	  NR	  
Fujita	  et	  al.,	  2010	  (14)	   	  14%	   	  82%	   	  86%	   	  	  4.90±.17	  
Mueser	  et	  al.,	  2006	  (2)	   	  27%	   	  NR4	   	  73%	   	  	  NR	  
Salyers,	  Godfrey	  et	  al.,	  
2009	  (17)	  
	  31%2	   	  NR	   	  NR	   	  	  4.5±.3	  
Salyers,	  Hicks	  et	  al.,	  2009	  
(18)	  
	  21%ª	   	  NR	   	  65%ª	   	  	  NR	  
Salyers,	  et	  al.,	  2010(15)	   26%	   	  	  NR	   	  15%	   	  	  4.40±.28	  	  
Salyers,	  et	  al.,	  2011(16)	   25%	   	  	  NR	   	  	  47%	   	  	  ≥4.0	  
Rychener	  et	  al.,	  2009(41)	   	  22%	   NR	   	  	  17%	   NR	  
Bartholomew	  et	  al.,	  
2010(25)	  
	  NR	   NR	   	  	  NR	   3.62	  
Roe	  et	  al.,	  2007(26)	   	  NR3	   NR	   	  	  63%6	   NR	  
NIEBP7	  studies(19,	  42,	  48)	   	  NR	   NR	   NR	   3.58±1.07	  
	  
Notes:	  NR	  =	  Not	  Reported	  
1Rate	  reported	  for	  IMR	  and	  control	  participants	  combined.	  
2Rate	  reported	  across	  sites.	  Individual	  sites	  ranged	  from	  10%-­‐50%.	  
3Dropout	  rate	  was	  reported	  for	  the	  Israeli	  sample	  (3/8),	  but	  not	  the	  US	  sample.	  
4	  U.S.:	  8	  of	  	  9	  attended	  	  ≥	  50%	  of	  sessions;	  6	  of	  9	  attended	  100%	  of	  sessions.	  
Australia:	  	  Six	  of	  10	  attended	  100%	  of	  sessions.	  
5Average	  across	  study	  sites.	  When	  measured	  at	  several	  time-­‐points,	  the	  last	  time-­‐point	  is	  reported.	  
6Reported	  for	  Israeli	  sample	  only.	  
7National	  Implementing	  Evidence-­‐Based	  Practices	  Project	  
  
